Tersis Technologies, Inc, formerly International Consolidated Companies, Inc., through its subsidiary, BluDog Products LLC, sells cannabidiol (CBD) products for pets. The Company is engaged in the business of developing and marketing specialized CBD products for the pet and animal markets. Its subsidiary, AG Tech Carbon LLC, provides both technology and consulting services to bamboo and eucalyptus growers, carbon footprint reduction activists, and industry professionals.

Employees

Sector

Drug Retailers

More about the company

Market Cap	23.38T 20.78T 19.37T 17.65T 33.3T 22.51L 33.62T 2L 90.98T 11.48L 87.75T 85.85T 36.89L	P/E 2009	-23.4x	P/E 2010	-0.09x
Enterprise Value	-7L -6L -6L -6L -10.42L -7.04Cr -10.52L -73.43L -28.46L -3.59Cr -27.45L -26.85L -12Cr	EV / Sales 2009	3x	EV / Sales 2010	-1.71x
Free-Float	4.16%	Yield 2009 *	-	Yield 2010	-

21/07	Tersis Technologies, Inc. Announces Appointment of Vaughan B. Adnams to Chief Investment & Capital Markets Officer, Effective July 20, 2026	CI
04/06	Tersis Technologies, Inc. Announces Appointment of Scott St. John to Chief Strategic Development Officer	CI
05/03	Tersis Technologies Inc. Announces Appointment of Hugo Mijares as Chief Architectural Officer, Effective 4 March 2026	CI
22/21/22	International Consolidated Companies, Inc. completed the acquisition of SoundTech AI, Inc for $150 million	CI
15/21/15	International Consolidated Companies, Inc. executed a letter of intent to acquire SoundTech AI, Inc	CI
13/21/13	International Consolidated Companies, Inc. completed the acquisition of Blue Plant Farms LLC.	CI
20/18/20	Bludog Products LLC Forms Strategic Partnership with Natures Renewable LLC	CI
12/18/12	International Consolidated Companies, Inc. completed the acquisition of American Nutritional Products, Inc.	CI
13/18/13	International Consolidated Companies, Inc. agreed to acquire American Nutritional Products, Inc.	CI
14/17/14	International Consolidated Companies, Inc. announced that it expects to receive $100 million in funding	CI
22/17/22	International Consolidated Companies, Inc. Enters into Licensing Agreement with CBD Medicinals, LLC	CI
13/17/13	International Consolidated Companies, Inc. Enters into an Exclusive License Agreement with Brooks Kelly Research, LLC	CI
01/17/01	International Consolidated Companies, Inc. entered into a letter of intent to acquire BluDog Products LLC.	CI

30/09	Tersis Technologies Files U.S. Provisional Patent Application to Turn Waste-Derived Carbon into Energy-Storage Material	NE
24/09	Tersis Technologies Hosts Private Climate Week Salon in New York	NE
03/09	Tersis Technologies Engages DIFFRNT Developments to Lead Web Development and Digital Infrastructure	NE
02/09	Tersis Technologies and Flux Core Sign MOU to Advance Decentralized Data Centers and Sustainable AI Compute	NE
24/08	Tersis Technologies and Ameri-Green Environmental Recycling Sign MOU for First Planned U.S. Commercial Deployment of SynGenic V3 Technology	NE

Manager	Title	Age	Since
Antonio Uccello CEO	Chief Executive Officer	58	28/01/2002
Vaughan Adnams CIO	Chief Investment Officer	-	20/07/2026
Scott John PRN	Corporate Officer/Principal	-	03/06/2026

Director	Title	Age	Since
Antonio Uccello CHM	Chairman	58	28/01/2002
Cortland J. Ornburg BRD	Director/Board Member	-	-
Thomas J. Megale BRD	Director/Board Member	-	-

International Consolidated Companies Inc Share Price OTC Bulletin Board

Stocks

US4593571098

Drug Retailers

Valuation: International Consolidated Companies Inc

Latest news: International Consolidated Companies Inc

Press Releases: International Consolidated Companies Inc

Quotes and Performance

Managers and Directors: International Consolidated Companies Inc

Cannabis Product Retailers

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTERNATIONAL CONSOLIDATED COMPANIES INC	+20.00%	-.--%	-	-	4.86Cr
JD HEALTH INTERNATIONAL INC.	-3.78%	-1.25%	-48.07%	-14.68%	1.41TCr
RAIA DROGASIL S.A.	+5.81%	+7.38%	+10.38%	-27.36%	651.38Cr
MATSUKIYOCOCOKARA & CO.	-0.71%	-3.63%	-16.66%	-7.34%	606.22Cr
TSURUHA HOLDINGS INC.	-1.67%	-4.89%	-11.03%	+2.13%	592.31Cr
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-1.75%	-0.35%	-57.73%	-42.32%	579.89Cr
YIFENG PHARMACY CHAIN CO., LTD.	+1.30%	+5.57%	-5.44%	-20.24%	421.5Cr
NAHDI MEDICAL COMPANY	+0.11%	-0.38%	-24.71%	-38.45%	315.43Cr
COSMOS PHARMACEUTICAL CORPORATION	-0.21%	-1.51%	-25.42%	-17.83%	311.46Cr
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+2.08%	+3.70%	+10.37%	-27.63%	309.14Cr
Average	+2.12%	-0.41%	-18.70%	-21.52%	577.26Cr
Weighted average by Cap.	-0.52%	-0.76%	-24.22%	-19.43%

	2009	2010
Net sales	1.09Cr 96.98L 90.39L 82.4L 1.55Cr 105.07Cr 1.57Cr 11Cr 4.25Cr 54Cr 4.1Cr 4.01Cr 172.21Cr	3L 3L 3L 2L 4L 3.02Cr 5L 31.47L 12.2L 1.54Cr 11.76L 11.51L 4.95Cr
Net income	-12.96L -11.52L -10.74L -10L -18.46L -12Cr -18.64L -1.3Cr -50.44L -6.36Cr -48.65L -47.59L -20Cr	-23.66L -21.03L -19.6L -17.87L -33.71L -23Cr -34.03L -2.38Cr -92.1L -12Cr -88.83L -86.91L -37Cr
Net Debt	7L 6L 6L 5L 9L 6.41Cr 10L 66.84L 25.9L 3.27Cr 24.99L 24.44L 11Cr	-8L -7L -6L -6L -10.75L -7.27Cr -10.85L -75.77L -29.37L -3.71Cr -28.33L -27.71L -12Cr